Neutrophil membrane fusogenic nanoliposomal leonurine for targeted ischemic stroke therapy via remodeling cerebral niche and restoring blood-brain barrier integrity

Ischemic stroke (IS) constitutes the leading cause of global morbidity and mortality. Neuroprotectants are essential to ameliorate the clinical prognosis, but their therapeutic outcomes are tremendously compromised by insufficient delivery to the ischemic lesion and intricate pathogenesis associated...

Full description

Bibliographic Details
Main Authors: Zhuang Tang, Shiyu Meng, Zhiling Song, Xiaoxue Yang, Xinzhi Li, Hui Guo, Meirong Du, Jun Chen, Yi Zhun Zhu, Xiaolin Wang
Format: Article
Language:English
Published: Elsevier 2023-06-01
Series:Materials Today Bio
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2590006423001345
_version_ 1797796391992426496
author Zhuang Tang
Shiyu Meng
Zhiling Song
Xiaoxue Yang
Xinzhi Li
Hui Guo
Meirong Du
Jun Chen
Yi Zhun Zhu
Xiaolin Wang
author_facet Zhuang Tang
Shiyu Meng
Zhiling Song
Xiaoxue Yang
Xinzhi Li
Hui Guo
Meirong Du
Jun Chen
Yi Zhun Zhu
Xiaolin Wang
author_sort Zhuang Tang
collection DOAJ
description Ischemic stroke (IS) constitutes the leading cause of global morbidity and mortality. Neuroprotectants are essential to ameliorate the clinical prognosis, but their therapeutic outcomes are tremendously compromised by insufficient delivery to the ischemic lesion and intricate pathogenesis associated with neuronal damage, oxidative stress, inflammation responses, blood-brain barrier (BBB) dysfunction, etc. Herein, a biomimetic nanosystem (Leo@NM-Lipo) composed of neutrophil membrane-fused nanoliposomal leonurine (Leo) is constructed, which can not only efficiently penetrate and repair the disrupted BBB but also robustly remodel the harsh cerebral microenvironment to reverse ischemia-reperfusion (I/R) injury. More specifically, the neutrophil membrane inherits the BBB penetrating, infarct core targeting, inflammation neutralization, and immune evasion properties of neutrophils, while Leo, a naturally occurring neuroprotectant, exerts pleiotropic effects to attenuate brain damage. Remarkably, comprehensive investigations disclose the critical factors influencing the targetability and therapeutic performances of biomimetic nanosystems. Leo@NM-Lipo with a low membrane protein-to-lipid ratio of 1:10 efficiently targets the ischemic lesion and rescues the injured brain by alleviating neuronal apoptosis, oxidative stress, neuroinflammation, and restoring BBB integrity in transient middle cerebral artery occlusion (tMCAO) rats. Taken together, our study provides a neutrophil-mimetic nanoplatform for targeted IS therapy and sheds light on the rational design of biomimetic nanosystems favoring wide medical applications.
first_indexed 2024-03-13T03:32:23Z
format Article
id doaj.art-5f887eb63e094939ad473c855c28679c
institution Directory Open Access Journal
issn 2590-0064
language English
last_indexed 2024-03-13T03:32:23Z
publishDate 2023-06-01
publisher Elsevier
record_format Article
series Materials Today Bio
spelling doaj.art-5f887eb63e094939ad473c855c28679c2023-06-24T05:18:45ZengElsevierMaterials Today Bio2590-00642023-06-0120100674Neutrophil membrane fusogenic nanoliposomal leonurine for targeted ischemic stroke therapy via remodeling cerebral niche and restoring blood-brain barrier integrityZhuang Tang0Shiyu Meng1Zhiling Song2Xiaoxue Yang3Xinzhi Li4Hui Guo5Meirong Du6Jun Chen7Yi Zhun Zhu8Xiaolin Wang9School of Pharmacy and State Key Laboratory of Quality Research in Chinese Medicine, Macau University of Science and Technology, Macao 999078, ChinaSchool of Pharmacy and State Key Laboratory of Quality Research in Chinese Medicine, Macau University of Science and Technology, Macao 999078, ChinaSchool of Pharmacy and State Key Laboratory of Quality Research in Chinese Medicine, Macau University of Science and Technology, Macao 999078, ChinaSchool of Pharmacy and State Key Laboratory of Quality Research in Chinese Medicine, Macau University of Science and Technology, Macao 999078, ChinaSchool of Pharmacy and State Key Laboratory of Quality Research in Chinese Medicine, Macau University of Science and Technology, Macao 999078, ChinaSchool of Chemical Engineering and Technology, Sun Yat-sen University, Zhuhai 519082, ChinaSchool of Pharmacy and State Key Laboratory of Quality Research in Chinese Medicine, Macau University of Science and Technology, Macao 999078, China; NHC Key Lab of Reproduction Regulation (Shanghai Institute of Planned Parenthood Research), Shanghai Key Laboratory of Female Reproductive Endocrine Related Diseases, Hospital of Obstetrics and Gynecology, Fudan University Shanghai Medical College, Shanghai 200032, ChinaSchool of Pharmacy, Fudan University, Shanghai 201203, ChinaSchool of Pharmacy and State Key Laboratory of Quality Research in Chinese Medicine, Macau University of Science and Technology, Macao 999078, China; Corresponding author.School of Pharmacy and State Key Laboratory of Quality Research in Chinese Medicine, Macau University of Science and Technology, Macao 999078, China; Corresponding author.Ischemic stroke (IS) constitutes the leading cause of global morbidity and mortality. Neuroprotectants are essential to ameliorate the clinical prognosis, but their therapeutic outcomes are tremendously compromised by insufficient delivery to the ischemic lesion and intricate pathogenesis associated with neuronal damage, oxidative stress, inflammation responses, blood-brain barrier (BBB) dysfunction, etc. Herein, a biomimetic nanosystem (Leo@NM-Lipo) composed of neutrophil membrane-fused nanoliposomal leonurine (Leo) is constructed, which can not only efficiently penetrate and repair the disrupted BBB but also robustly remodel the harsh cerebral microenvironment to reverse ischemia-reperfusion (I/R) injury. More specifically, the neutrophil membrane inherits the BBB penetrating, infarct core targeting, inflammation neutralization, and immune evasion properties of neutrophils, while Leo, a naturally occurring neuroprotectant, exerts pleiotropic effects to attenuate brain damage. Remarkably, comprehensive investigations disclose the critical factors influencing the targetability and therapeutic performances of biomimetic nanosystems. Leo@NM-Lipo with a low membrane protein-to-lipid ratio of 1:10 efficiently targets the ischemic lesion and rescues the injured brain by alleviating neuronal apoptosis, oxidative stress, neuroinflammation, and restoring BBB integrity in transient middle cerebral artery occlusion (tMCAO) rats. Taken together, our study provides a neutrophil-mimetic nanoplatform for targeted IS therapy and sheds light on the rational design of biomimetic nanosystems favoring wide medical applications.http://www.sciencedirect.com/science/article/pii/S2590006423001345Neutrophil-mimeticLeonurineIschemic strokeTargeted therapyBlood-brain barrier
spellingShingle Zhuang Tang
Shiyu Meng
Zhiling Song
Xiaoxue Yang
Xinzhi Li
Hui Guo
Meirong Du
Jun Chen
Yi Zhun Zhu
Xiaolin Wang
Neutrophil membrane fusogenic nanoliposomal leonurine for targeted ischemic stroke therapy via remodeling cerebral niche and restoring blood-brain barrier integrity
Materials Today Bio
Neutrophil-mimetic
Leonurine
Ischemic stroke
Targeted therapy
Blood-brain barrier
title Neutrophil membrane fusogenic nanoliposomal leonurine for targeted ischemic stroke therapy via remodeling cerebral niche and restoring blood-brain barrier integrity
title_full Neutrophil membrane fusogenic nanoliposomal leonurine for targeted ischemic stroke therapy via remodeling cerebral niche and restoring blood-brain barrier integrity
title_fullStr Neutrophil membrane fusogenic nanoliposomal leonurine for targeted ischemic stroke therapy via remodeling cerebral niche and restoring blood-brain barrier integrity
title_full_unstemmed Neutrophil membrane fusogenic nanoliposomal leonurine for targeted ischemic stroke therapy via remodeling cerebral niche and restoring blood-brain barrier integrity
title_short Neutrophil membrane fusogenic nanoliposomal leonurine for targeted ischemic stroke therapy via remodeling cerebral niche and restoring blood-brain barrier integrity
title_sort neutrophil membrane fusogenic nanoliposomal leonurine for targeted ischemic stroke therapy via remodeling cerebral niche and restoring blood brain barrier integrity
topic Neutrophil-mimetic
Leonurine
Ischemic stroke
Targeted therapy
Blood-brain barrier
url http://www.sciencedirect.com/science/article/pii/S2590006423001345
work_keys_str_mv AT zhuangtang neutrophilmembranefusogenicnanoliposomalleonurinefortargetedischemicstroketherapyviaremodelingcerebralnicheandrestoringbloodbrainbarrierintegrity
AT shiyumeng neutrophilmembranefusogenicnanoliposomalleonurinefortargetedischemicstroketherapyviaremodelingcerebralnicheandrestoringbloodbrainbarrierintegrity
AT zhilingsong neutrophilmembranefusogenicnanoliposomalleonurinefortargetedischemicstroketherapyviaremodelingcerebralnicheandrestoringbloodbrainbarrierintegrity
AT xiaoxueyang neutrophilmembranefusogenicnanoliposomalleonurinefortargetedischemicstroketherapyviaremodelingcerebralnicheandrestoringbloodbrainbarrierintegrity
AT xinzhili neutrophilmembranefusogenicnanoliposomalleonurinefortargetedischemicstroketherapyviaremodelingcerebralnicheandrestoringbloodbrainbarrierintegrity
AT huiguo neutrophilmembranefusogenicnanoliposomalleonurinefortargetedischemicstroketherapyviaremodelingcerebralnicheandrestoringbloodbrainbarrierintegrity
AT meirongdu neutrophilmembranefusogenicnanoliposomalleonurinefortargetedischemicstroketherapyviaremodelingcerebralnicheandrestoringbloodbrainbarrierintegrity
AT junchen neutrophilmembranefusogenicnanoliposomalleonurinefortargetedischemicstroketherapyviaremodelingcerebralnicheandrestoringbloodbrainbarrierintegrity
AT yizhunzhu neutrophilmembranefusogenicnanoliposomalleonurinefortargetedischemicstroketherapyviaremodelingcerebralnicheandrestoringbloodbrainbarrierintegrity
AT xiaolinwang neutrophilmembranefusogenicnanoliposomalleonurinefortargetedischemicstroketherapyviaremodelingcerebralnicheandrestoringbloodbrainbarrierintegrity